Advertisement
Advertisement
Advertisement
Advertisement
Clario Unveils AI-Boosted ECG Quality Score Tool for Advanced Cardiac Safety Assessment

Clario Unveils AI-Boosted ECG Quality Score Tool for Advanced Cardiac Safety Assessment

Clario Unveils AI-Boosted ECG Quality Score Tool for Advanced Cardiac Safety Assessment

Clario Unveils AI-Boosted ECG Quality Score Tool for Advanced Cardiac Safety Assessment

Advertisement
  • Clario has rolled out a new ECG Quality Score tool that uses AI/ML.
  • The tool is designed to help sponsors collect higher quality data.
  • The tool is initially being rolled out to Clario Certified Sites.
Advertisement

Clario, a leading healthcare research technology company, has unveiled its revolutionary AI-powered ECG Quality Score tool.

This cutting-edge technology marks a significant milestone in Clario’s commitment to delivering unparalleled accuracy and efficiency in cardiac safety assessments during clinical trials.

Empowering Accuracy Through AI/ML Approach:

The AI-powered ECG Quality Score tool utilizes an advanced Artificial Intelligence/Machine Learning (AI/ML) approach trained on an extensive dataset of over 80,000 Phase 1 Healthy Volunteer ECGs. This enables the tool to provide comprehensive information about the quality of continuously acquired ECG data. By doing so, it offers a proactive approach to assessing study quality, allowing Clario to support sponsors in monitoring and remediation in near real-time.

Proactive Quality Assurance:

Acting as a proactive insurance policy for prospective studies with planned Early Precision QT (EPQT) assessment, the tool ensures that the collected continuous ECG data meets the required quality standards. This capability is particularly valuable for studies where ECG data may be stored for potential assessment in the future, instilling confidence in sponsors regarding the data’s accuracy and reliability.

Advertisement

Ellen Street’s Enthusiasm:

Ellen Street, Executive Vice President, Cardiac Safety at Clario, expressed her enthusiasm for the ECG Quality Score tool. She stated, “Clario’s ECG Quality Score tool embodies our unwavering commitment to advancing trials and technologies through the use of AI/ML. We aim to provide sponsors with better insights into cardiac safety earlier in the drug development process and equip them with the tools needed to make informed decisions and collect higher quality data.”

Comprehensive Reporting for Enhanced Assurance:

The ECG Quality Score tool includes two detailed reports—the Early Precision QT® Quality Summary Report and the Early Precision QT® Quality Detailed Report. Together, these reports offer granular insights into the quality of ECG data collected, providing sponsors with valuable information and reassurance. This comprehensive reporting system enhances data quality assurance, reduces risks, and ultimately improves the likelihood of achieving definitive trial outcomes.

Rollout to Clario Certified Sites:

Initially, the ECG Quality Score tool will be rolled out to Clario Certified Sites as part of the company’s strategic focus on introducing new technology to its closest partners first. This phased implementation ensures a controlled and efficient integration of the tool into Clario’s cardiac safety services.

Advertisement

Also Read

Flywheel and Microsoft Forge Partnership for AI Collaboration
Flywheel and Microsoft Forge Partnership for AI Collaboration

Flywheel launches AI tool on Azure to accelerate medical imaging research. Flywheel...

Advertisement
Advertisement
Read More News On

Catch all the Sci-Tech News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story